Is forcing a school shooter to donate his brain to scientific study unethical?
Here's how embracing a comprehensive, patient-centered approach and staying informed about emerging treatments can help mental health professionals make a difference in the lives of patients with TRD.
Cannabis use disorder and nonadherence: How can we best educate patients?
How to help individuals caught in human trafficking: person-centered, culturally humble, trauma-informed care.
How do we find the right treatments for our patients with schizophrenia at every step of their journey?
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
In a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.
As the COP-26 (Conference of the Parties) gets ready to convene to discuss climate change, it is crucial for them to consider brain science.
Faced with the trend toward shorter length of stay in inpatient psychiatric units, practitioners and patients in need of care face dramatic changes in treatment.
The president of the San Diego Psychiatric Society gives us a glimpse into the city for the upcoming 2022 Annual Psychiatric Times World CME Conference.
Experts share their best practices and tips.
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
Research reveals that IV haloperidol and ziprasidone are safe for treating delirium in patients that are critically ill, showing minimal impact on QTc intervals.
Disruptions to cognitive control, as well as to emotional processes, are implicated in a wide range of psychiatric disorders.
Neurosurgeon Brian Kopell, MD, discusses the potential of deep brain stimulation for treatment-resistant depression, aiming to reduce stigma and improve patient care.
Here's how medical practitioners and researchers can influence AI reasoning and influence in the future of AI development and deployment.
Combination therapy of TMS and ketamine could enhance brain perfusion and neuroplasticity.
Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.
Emergency psychiatry navigates complex ethical dilemmas, balancing patient safety, autonomy, and confidentiality in high-stakes situations.
Online environments have revolutionized the lives of young SGM individuals, but also created unforeseen issues...
Learn more about the latest advancements in schizophrenia treatment and the ongoing battle against stigma during Mental Health Awareness Month.
Individuals with schizophrenia have experienced an increase in psychiatric, medical, and treatment risks because of the COVID-19 pandemic.
"This pandemic represents an unprecedented time that requires a psychiatrist’s vigilance in identifying patients at risk for COVID-19–induced psychosis."
Regular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.
Parenteral ketamine is commonly used to manage agitation that is deemed severe and obstructive to necessary medical evaluation and treatment. But what does this suggest about the relationship between medicine and society?
Brain Capital: a fresh approach to technologies and investing.
Elizabeth Lowenhaupt, MD, CCHP, shares her insights and experiences on correctional psychiatry and juvenile mental health as she looks toward the future of the field.
Psychopharmacology, while an essential tool, is only one of those tools.